A Newborn's Test Results Changed Everything—But So Did a Bold Medical Decision

Seven Days of Joy, Then a Diagnosis

When Lupita Vasquez welcomed her son Jesse into the world in 2024, it was one of the happiest days of her life. She described the pregnancy as uneventful and normal, with no early warning signs that would foreshadow what was to come.

But just a week after his birth, a routine heel-prick test revealed something unexpected. The results flagged spinal muscular atrophy (SMA), a rare genetic condition that affects muscle movement in infants. It wasn't the kind of news you expect when everything seems perfect.

"I remember getting the phone call and not knowing what SMA was. I went straight to Google, which I shouldn't have done, because it made me even more scared," Vasquez recalled. "I cried a lot. I was so confused and wondering what I did wrong for my baby to be born with something like this."

For most parents, newborn screening tests are routine—more than 98% of U.S. infants receive them. But when the results show something abnormal, it can feel like a sudden shift in reality.

The Race Against Time

Jesse was diagnosed with Type 1 SMA, the most severe form that typically manifests in the first six months of life. The condition impacts motor neurons, leading to progressive muscle weakness—often affecting breathing, swallowing, and mobility.

But the diagnosis didn't define Jesse's future. It became the starting point for a medical journey that would soon become a story of progress and resilience.

After an initial round of Evrysdi treatment, Jesse's case advanced to a more intensive regimen involving SPINRAZA—a high-dose variant approved by the FDA earlier this year. This new dosing approach allows for higher concentrations of the drug directly into the spinal fluid, offering improved outcomes in children like Jesse.

A Family's Bold Move

Vasquez had always been cautious about medical interventions. When her neurologist suggested the high-dose SPINRAZA therapy, it was a moment that tested both her resolve and her trust in the process. The procedure involved sedation twice—two weeks apart—and then maintenance doses every four months.

"We were kind of scared because of the process with SPINRAZA, it being injected into the spine, and Jesse having to be put to sleep," she said. "I was really afraid of that after everything he'd already gone through with so many appointments, blood draws and tests."

Yet, despite her fears, Vasquez made a decision that would alter their trajectory. She chose to proceed.

"I'm so happy that I took the risk," she said.

The Miracle That Followed

Within weeks of receiving his first high-dose SPINRAZA treatment, Jesse began showing signs of progress—pulling himself up to stand and cruising along walls. A month later, he was walking independently.

"It made everyone in the family cry because we were already prepared that maybe our baby wasn't ever going to walk," she said. "It was everything we'd ever hoped and prayed for."

These weren't just words; they were moments that redefined what seemed possible. Vasquez saw her son not as a child defined by his diagnosis but one who could thrive despite it.

Jesse's transformation after high-dose SPINRAZA treatment.

Today, at age two, Jesse continues to exceed expectations. Though he tires easily and still works on balance, his story serves as a powerful reminder of how timely medical interventions can alter life's trajectory. His family now sees him as a vibrant child who loves soccer, music, cars—and is full of adventure.

What This Means for Others

Vasquez has since become an advocate, reaching out to other parents who might be facing similar challenges. Her advice is simple: don't spiral into worst-case scenarios online; instead, connect with support groups and focus on your child's journey one day at a time.

"Until I connected with other moms who felt exactly like me, that's when I started to feel a little better," she shared. "Take it a day at a time and find a support group."

Her story isn't just about medical science—it's about the resilience of families and the power of hope. When medical advances meet informed decisions, sometimes the result is more than miraculous; it's transformative.

Looking Ahead

As research continues to evolve in treating SMA, including gene therapies like Zolgensma and newer formulations such as SPINRAZA's high-dose regimen, we're seeing a shift in how conditions once considered incurable are now managed with greater precision.

This isn't just about Jesse. It's about what medical progress can accomplish when families, doctors, and science work together to give children the best chance at life. The emotional weight of a diagnosis may be heavy, but so too is the joy that follows when we act swiftly and decisively.

In a world where health outcomes often depend on early detection and intervention, stories like Jesse's offer clarity—and encouragement—that even in the darkest moments, there is always light ahead.